- Stereotaxis (STXS +8.9%) gains from an upbeat article in Seeking Alpha today.
- The post, which featured an interview with life science investor DAFNA Capital, calls STXS the leading robotics company in the endovascular space, with the ability to become the 'Intuitive Surgical (ISRG)' of catheter procedures.
- DAFNA says ISRG has amongst the highest operating margins in the medical device industry and is an extremely profitable company.
- STXS is also a business which can have extremely high profit margins, and when it reaches the appropriate scale to start focusing on profit, the investor thinks that shareholders will be very handsomely rewarded.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs